J9326 – Injection, telisotuzumab vedotin-tllv, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9326
- Long description
- Injection, telisotuzumab vedotin-tllv, 1 mg
- Short description
- Telisotuzumab vedotin-tllv
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- Added
- January 1, 2026
- Last change
- January 1, 2026 – No change
Frequently asked questions
What is HCPCS code J9326?
J9326 is a HCPCS Level II code for injection, telisotuzumab vedotin-tllv, 1 mg.
Does Medicare cover J9326?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9318 – Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319 – Injection, romidepsin, lyophilized, 0.1 mg
- J9320 – Injection, streptozocin, 1 gram
- J9321 – Injection, epcoritamab-bysp, 0.16 mg
- J9322 – Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323 – Injection, pemetrexed ditromethamine, 10 mg
- J9324 – Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325 – Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9328 – Injection, temozolomide, 1 mg
- J9329 – Injection, tislelizumab-jsgr, 1mg
- J9330 – Injection, temsirolimus, 1 mg
- J9331 – Injection, sirolimus protein-bound particles, 1 mg
- J9332 – Injection, efgartigimod alfa-fcab, 2mg
- J9333 – Injection, rozanolixizumab-noli, 1 mg
- J9334 – Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340 – Injection, thiotepa, 15 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.